Stay updated on GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial
Sign up to get notified when there's something new on the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page.

Latest updates to the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page
- Check7 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe study record page displays a 403 Forbidden message and a Home link instead of the study content.SummaryDifference0.5%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study record page now displays a 403 Forbidden error with a basic layout and a '403' header, instead of the full study content. The usual study details and related resources appear inaccessible in this view.SummaryDifference18%

- Check42 days agoChange DetectedNo changes were detected in the listed website content for this study page; the content remains unchanged from the referenced version.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page adds a new NIH funding identifier under Other Study ID Numbers and updates the page revision to v3.6.6, replacing the previous 3.6.5 revision.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor backend update to the record; no study details or public content appear to have changed.SummaryDifference0.0%

Stay in the know with updates to GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page.